HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Single rituximab dose as treatment for membranoproliferative glomerulonephritis relapse after kidney transplant.

AuthorsLeonidas Cruzado Vega, Alba Santos García
JournalNefrologia (Nefrologia (Engl Ed)) 2021 Sep-Oct Vol. 41 Issue 5 Pg. 601-603 ISSN: 2013-2514 [Electronic] Spain
PMID36165147 (Publication Type: Letter)
Chemical References
  • Rituximab
Topics
  • Glomerulonephritis, Membranoproliferative (drug therapy)
  • Humans
  • Kidney Transplantation
  • Plasmapheresis
  • Recurrence
  • Rituximab (therapeutic use)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: